Challenging Research Models to Improve Health Equity
Podcast: BioSpacePublished On: Thu Jun 20 2024
Description: Diversity, equity and inclusion (DEI) continues to be a challenge for drug and medical device developers. While there has been some improvement in clinical trials, our guests note that unless there is a commercial or regulatory need, DEI is still an afterthought for many developers when designing clinical trials. Host Lori Ellis, Head of Insights, BioSpace Guests Ali Pashazadeh, CEO,Treehill Partners Charlotte Jones-Burton, Board Member, bluebird bio; Founder & President, Women of Color in Pharma Chia Chia Sun, Chief Commercial Officer, Fab Biopharma; CEO, Damiva Phyllis Greenberger, Senior Vice President, Policy & Regulatory, Healthy Women Todd Rudo, Chief Medical Officer, Clario
The note was deleted
The note was saved
Your message was sent